Single-cell analysis of a high-grade serous ovarian cancer cell line reveals transcriptomic changes and cell subpopulations sensitive to epigenetic combination treatment.
Ovarian cancer (OC) is a lethal gynecological malignancy with a five-year survival rate of only 46%. Development of resistance to platinum-based chemotherapy is a common cause of high mortality rates among OC patients. Tumor and transcriptomic heterogeneity are drivers of platinum resistance in OC....
Main Authors: | Shruthi Sriramkumar, Tara X Metcalfe, Tim Lai, Xingyue Zong, Fang Fang, Heather M O'Hagan, Kenneth P Nephew |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2022-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0271584 |
Similar Items
-
Single-cell analysis of a high-grade serous ovarian cancer cell line reveals transcriptomic changes and cell subpopulations sensitive to epigenetic combination treatment
by: Shruthi Sriramkumar, et al.
Published: (2022-01-01) -
Platinum-induced mitochondrial OXPHOS contributes to cancer stem cell enrichment in ovarian cancer
by: Shruthi Sriramkumar, et al.
Published: (2022-05-01) -
A Novel ALDH1A1 Inhibitor Blocks Platinum-Induced Senescence and Stemness in Ovarian Cancer
by: Vaishnavi Muralikrishnan, et al.
Published: (2022-07-01) -
The Role of Inflammation and Inflammatory Mediators in the Development, Progression, Metastasis, and Chemoresistance of Epithelial Ovarian Cancer
by: Sudha S. Savant, et al.
Published: (2018-07-01) -
Ovarian Cancer Stem Cells: Role in Metastasis and Opportunity for Therapeutic Targeting
by: Xingyue Zong, et al.
Published: (2019-07-01)